$129.08
0.49% yesterday
NYSE, Feb 04, 10:10 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$129.10
+16.06 14.21% 1M
+20.47 18.84% 6M
+15.99 14.14% YTD
+17.45 15.63% 1Y
-0.61 0.47% 3Y
+40.87 46.32% 5Y
+83.93 185.81% 10Y
NYSE, Closing price Tue, Feb 04 2025
+0.65 0.51%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Market capitalization $223.92b
P/E (TTM) P/E ratio 16.85
P/S ratio (TTM) P/S ratio 5.34
P/B ratio (TTM) P/B ratio 5.63
Dividend yield 1.74%
Last dividend (FY24) $2.24
Revenue growth (TTM) Revenue growth 4.59%
Revenue (TTM) Revenue $41.95b
EBIT (operating result TTM) EBIT $6.90b
Cash position $7.79b
EPS (TTM) EPS $7.66
Short interest 0.83%
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Abbott Laboratories forecast:

21x Buy
70%
9x Hold
30%

Analyst Opinions

30 Analysts have issued a Abbott Laboratories forecast:

Buy
70%
Hold
30%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
41,950 41,950
5% 5%
100%
- Direct Costs 20,116 20,116
0% 0%
48%
24,245 24,245
21% 21%
58%
- Selling and Administrative Expenses 12,116 12,116
59% 59%
29%
- Research and Development Expense 2,821 2,821
4% 4%
7%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 6,897 6,897
7% 7%
16%
Net Profit 13,386 13,386
135% 135%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Neutral
PRNewsWire
about 14 hours ago
New survey shows 40% of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma1 70% of people with diabetes said supportive comments from others can significantly boost their motivation to manage their condition1 Abbott launches film that highlights challenges of living life with diabetes ABBOTT PARK, Ill., Feb. 4, 2025 /PRNewswire/ -- 'One cupcake won'...
Positive
The Motley Fool
2 days ago
In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As most income seekers want to avoid this fate, they might consider turning to arguably the most elite group of dividend payers on the market: Dividend Kings.
Neutral
Seeking Alpha
7 days ago
The ProShares S&P 500 Dividend Aristocrat ETF posted its 3rd worst monthly return in December, falling by 7.69%. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 42 months of tracking these strategies, two strategies are generating a CAGR superior to NOBL.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today